OSMT - Osmotica Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
333.58M
Enterprise Value 3
530.14M
Trailing P/E
N/A
Forward P/E 1
-6.32
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.36
Price/Book (mrq)
2.40
Enterprise Value/Revenue 3
2.16
Enterprise Value/EBITDA 6
12.60

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-16.18%
S&P500 52-Week Change 318.19%
52 Week High 39.35
52 Week Low 32.20
50-Day Moving Average 34.96
200-Day Moving Average 33.76

Share Statistics

Avg Vol (3 month) 3129.84k
Avg Vol (10 day) 3236.23k
Shares Outstanding 551.93M
Float 7.33M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Nov 15, 2019) 4154.6k
Short Ratio (Nov 15, 2019) 41.67
Short % of Float (Nov 15, 2019) 41.95%
Short % of Shares Outstanding (Nov 15, 2019) 40.30%
Shares Short (prior month Oct 15, 2019) 4174.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -142.78%
Operating Margin (ttm)-5.61%

Management Effectiveness

Return on Assets (ttm)-1.28%
Return on Equity (ttm)-125.98%

Income Statement

Revenue (ttm)245.82M
Revenue Per Share (ttm)4.68
Quarterly Revenue Growth (yoy)-1.30%
Gross Profit (ttm)128.69M
EBITDA 42.06M
Net Income Avi to Common (ttm)-350.98M
Diluted EPS (ttm)-6.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.01M
Total Cash Per Share (mrq)1.89
Total Debt (mrq)274.02M
Total Debt/Equity (mrq)193.38
Current Ratio (mrq)2.13
Book Value Per Share (mrq)2.72

Cash Flow Statement

Operating Cash Flow (ttm)63.28M
Levered Free Cash Flow (ttm)66.98M